Literature DB >> 12029148

Identification of the principal serological immunodeterminants of African swine fever virus by screening a virus cDNA library with antibody.

S D Kollnberger1, B Gutierrez-Castañeda1, M Foster-Cuevas1, A Corteyn1, R M E Parkhouse1.   

Abstract

Protective immunity to African swine fever virus (ASFV) may involve a combination of both serological and cellular mechanisms. This work is focused on the identification of the possible relevant serological immunodeterminants of immunity. Thus, 14 serological immunodeterminants of ASFV have been characterized by exhaustive screening of a representative lambda phage cDNA expression library of the tissue culture-adapted Ba71V strain of ASFV. The library was constructed using RNA extracted from Vero cells infected for 3, 6, 9 and 12 h. A total of 150 clones was selected arbitrarily by antibody screening of the library with a polyclonal antiserum from a domestic pig surviving infection with the virulent Malta isolate of ASFV. Sequencing of these clones permitted identification of 14 independent viral proteins that stimulated an antibody response. These included six proteins encoded by previously unassigned open reading frames (ORFs) (B602L, C44L, CP312R, E184L, K145R and K205R) as well as some of the more well-studied structural (A104R, p10, p32, p54 and p73) and non-structural proteins (RNA reductase, DNA ligase and thymidine kinase). Immunogenicity of these proteins was confirmed by demonstrating the corresponding antibodies in sera from pigs infected either with the Malta isolate or with the OURT88/3-OURT88/1 isolate combination. Furthermore, the majority of these ORFs were also recognized by immune antiserum from the natural host, the bush pig, following secondary challenge with the virulent Malawi (SINT90/1) isolate of ASFV. Thus, it is possible that some of these determinants may be important in protection against virus infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12029148     DOI: 10.1099/0022-1317-83-6-1331

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  22 in total

1.  Optimization and validation of recombinant serological tests for African Swine Fever diagnosis based on detection of the p30 protein produced in Trichoplusia ni larvae.

Authors:  D M Pérez-Filgueira; F González-Camacho; C Gallardo; P Resino-Talaván; E Blanco; E Gómez-Casado; C Alonso; J M Escribano
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

2.  Structural Design and Assessing of Recombinantly Expressed African Swine Fever Virus p72 Trimer in Saccharomyces cerevisiae.

Authors:  Kaiwen Meng; Yueping Zhang; Qi Liu; Yangnan Huyan; Wenzhuang Zhu; Ye Xiang; Geng Meng
Journal:  Front Microbiol       Date:  2022-06-14       Impact factor: 6.064

3.  Deletion of E184L, a Putative DIVA Target from the Pandemic Strain of African Swine Fever Virus, Produces a Reduction in Virulence and Protection against Virulent Challenge.

Authors:  Elizabeth Ramirez-Medina; Elizabeth Vuono; Ayushi Rai; Sarah Pruitt; Nallely Espinoza; Lauro Velazquez-Salinas; Sonia Pina-Pedrero; James Zhu; Fernando Rodriguez; Manuel V Borca; Douglas P Gladue
Journal:  J Virol       Date:  2021-10-20       Impact factor: 6.549

4.  Recombinant antigen targets for serodiagnosis of African swine fever.

Authors:  Carmina Gallardo; Ana Luísa Reis; Gladys Kalema-Zikusoka; Joana Malta; Alejandro Soler; Esther Blanco; R M E Parkhouse; Alexandre Leitão
Journal:  Clin Vaccine Immunol       Date:  2009-05-06

5.  Expression library immunization can confer protection against lethal challenge with African swine fever virus.

Authors:  Anna Lacasta; María Ballester; Paula L Monteagudo; Javier M Rodríguez; María L Salas; Francesc Accensi; Sonia Pina-Pedrero; Albert Bensaid; Jordi Argilaguet; Sergio López-Soria; Evelyne Hutet; Marie Frédérique Le Potier; Fernando Rodríguez
Journal:  J Virol       Date:  2014-09-10       Impact factor: 5.103

6.  Polymorphism analysis and supertype definition of swine leukocyte antigen class I molecules in three-way crossbred (Landrace, Duroc, and Yorkshire) pigs: implications for the vaccine development of African swine fever virus.

Authors:  Limin Ba; Zhenbao Wang; William J Liu; Dongxun Wu; Wangzhen Xiang; Peng Qi; Chunna Dong; Yanxin Hu; Ping Lu; Jin Xiao; Changyuan Yu
Journal:  Sci China Life Sci       Date:  2020-05-11       Impact factor: 6.038

Review 7.  African swine fever vaccines: a promising work still in progress.

Authors:  Laia Bosch-Camós; Elisabeth López; Fernando Rodriguez
Journal:  Porcine Health Manag       Date:  2020-07-02

8.  Identification and Immunogenicity of African Swine Fever Virus Antigens.

Authors:  Christopher L Netherton; Lynnette C Goatley; Ana Luisa Reis; Raquel Portugal; Rachel H Nash; Sophie B Morgan; Lynden Gault; Raquel Nieto; Veronica Norlin; Carmina Gallardo; Chak-Sum Ho; Pedro J Sánchez-Cordón; Geraldine Taylor; Linda K Dixon
Journal:  Front Immunol       Date:  2019-06-19       Impact factor: 7.561

Review 9.  Approaches and Perspectives for Development of African Swine Fever Virus Vaccines.

Authors:  Marisa Arias; Ana de la Torre; Linda Dixon; Carmina Gallardo; Ferran Jori; Alberto Laddomada; Carlos Martins; R Michael Parkhouse; Yolanda Revilla; Fernando And Jose-Manuel Rodriguez
Journal:  Vaccines (Basel)       Date:  2017-10-07

10.  Gene expression analysis of whole blood RNA from pigs infected with low and high pathogenic African swine fever viruses.

Authors:  Crystal Jaing; Raymond R R Rowland; Jonathan E Allen; Andrea Certoma; James B Thissen; John Bingham; Brenton Rowe; John R White; James W Wynne; Dayna Johnson; Natasha N Gaudreault; David T Williams
Journal:  Sci Rep       Date:  2017-08-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.